Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Bausch Health Companies Inc |
30/04 | 5,300 USD
-3,81% |
-3,81% |
|
Baxter |
30/04 | 31,170 USD
+0,61% |
+0,61% |
Bayer AG |
30/04 | 23,030 EUR
-0,60% |
-0,60% |
|
Beam Therapeutics Inc |
30/04 | 19,930 USD
+1,12% |
+1,12% |
|
Becton, Dickinson And Co. |
30/04 | 207,090 USD
+0,31% |
+0,31% |
|
BeiGene Ltd |
30/04 | 259,810 USD
+4,02% |
+4,02% |
|
Bellring Brands Inc |
30/04 | 77,140 USD
+0,53% |
+0,53% |
Benchmark Holdings plc |
30/04 | 21,200 GBX
+1,44% |
+1,44% |
|
Benitec Biopharma Inc |
30/04 | 13,590 USD
-0,66% |
-0,66% |
|
Beximco Pharmaceuticals Limited - GDR - Reg S |
30/04 | 40,000 GBX
0,00% |
0,00% |
|
BeyondSpring Inc |
30/04 | 1,740 USD
+12,26% |
+12,26% |
|
Bicycle Therapeutics Plc |
30/04 | 8,560 USD
+4,26% |
+4,26% |
|
Bio-Path Holdings Inc |
30/04 | 0,135 USD
-15,56% |
-15,56% |
|
Bio-Rad Laboratories Inc. |
21/04 | 234,410 USD
+4,05% |
+4,05% |
|
Bio-Rad Laboratories Inc. |
30/04 | 244,080 USD
+0,73% |
+0,73% |
|
Bio-Techne Corp |
30/04 | 50,350 USD
-0,30% |
-0,30% |
|
BioCardia Inc. |
30/04 | 3,140 USD
+2,95% |
+2,95% |
|
Biocryst Pharmaceuticals Inc. |
30/04 | 8,850 USD
+4,86% |
+4,86% |
|
Biogen |
30/04 | 121,080 USD
+0,76% |
+0,76% |
|
Biohaven Ltd |
30/04 | 22,120 USD
+1,10% |
+1,10% |
|
Biolife Solutions Inc |
30/04 | 24,110 USD
-2,43% |
-2,43% |
|
Bioline Rx Ltd |
30/04 | 3,470 USD
+7,76% |
+7,76% |
|
Biomarin Pharmaceutical Inc. |
30/04 | 63,690 USD
+0,65% |
+0,65% |
|
Biomerica Inc. |
30/04 | 3,620 USD
+0,28% |
+0,28% |
Biomerieux |
30/04 | 118,700 EUR
+2,06% |
+2,06% |
|
BiomX Inc |
30/04 | 0,609 USD
-2,06% |
-2,06% |
|
Bionano Genomics Inc |
30/04 | 3,990 USD
-3,86% |
-3,86% |
|
BioNTech SE |
30/04 | 104,150 USD
+0,14% |
+0,14% |
|
Biophytis |
30/04 | 0,166 EUR
-3,26% |
-3,26% |
|
BioRestorative Therapies Inc |
30/04 | 1,760 USD
+2,33% |
+2,33% |
BioSenic |
30/04 | 0,001 EUR
+7,69% |
+7,69% |
|
Biosig Technologies Inc |
30/04 | 1,030 USD
+11,94% |
+11,94% |
Biosyent Inc |
30/04 | 10,900 CAD
-0,73% |
-0,73% |
|
Biosynex |
30/04 | 1,365 EUR
-0,71% |
-0,71% |
|
Biotest AG |
30/04 | 30,000 EUR
0,00% |
0,00% |
|
Biotest AG |
30/04 | 42,400 EUR
0,00% |
0,00% |
|
BioVie Inc |
30/04 | 0,818 USD
-1,26% |
-1,26% |
|
BioXcel Therapeutics Inc |
30/04 | 1,850 USD
-7,04% |
-7,04% |
|
Black Diamond Therapeutics Inc |
30/04 | 1,700 USD
+6,25% |
+6,25% |
|
Bluebird bio Inc |
30/04 | 4,080 USD
-0,97% |
-0,97% |
|
Bluelinea SA |
30/04 | 0,675 EUR
+6,30% |
+6,30% |
|
Blueprint Medicines Corp |
30/04 | 89,500 USD
+1,15% |
+1,15% |
|
Boiron |
30/04 | 24,300 EUR
+0,41% |
+0,41% |
|
Bone Biologics Corp |
30/04 | 0,673 USD
-3,60% |
-3,60% |
|
Boston Scientific Corp. |
30/04 | 102,870 USD
+0,13% |
+0,13% |
|
Boundless Bio Inc. |
30/04 | 1,760 USD
+10,00% |
+10,00% |
|
BRAIN Biotech AG |
30/04 | 2,300 EUR
-1,29% |
-1,29% |
|
Brainstorm Cell Therapeutics, Inc. |
30/04 | 1,300 USD
+19,82% |
+19,82% |
|
Brainsway Ltd |
30/04 | 8,670 USD
-2,47% |
-2,47% |
|
BriaCell Therapeutics Corp |
30/04 | 4,460 USD
-2,83% |
-2,83% |
|
BridgeBio Pharma Inc |
30/04 | 38,360 USD
+5,33% |
+5,33% |
|
Bristol-Myers Squibb Co. |
30/04 | 50,200 USD
+1,99% |
+1,99% |
|
Bruker Corp |
30/04 | 40,060 USD
+0,55% |
+0,55% |